A Real-World, Multicenter, Retrospective study to evaluate the safety and efficacy of Calcipotriene/Betamethasone Dipropionate foam 0.005%/0.064% in patients with Plaque psoriasis
Latest Information Update: 09 May 2018
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- 09 May 2018 New trial record